Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Screening for the alpha-adducin Gly460Trp variant in hypertensive patients: a cost-effectiveness analysis.

Pharmacogenetics and genomics - 1 Feb 2006

Meckley Lisa M, Veenstra David L

Abstract excerpt

BACKGROUND: Studies have shown that approximately 80% of hypertensive patients do not take diuretics despite their recommendation as a first-line therapy. A recent study reported that hypertensive patients with the Gly460Trp variant in the alpha-adducin gene are more likely to benefit from diuretic therapy. The objective of this study was to evaluate the potential cost effectiveness of screening for the...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Calmodulin-Binding Proteins
Share to Cost-Benefit Analysis
Share to Diuretics

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Hypertension

Share to Markov Chains

Share to Mass Screening

Share to Pharmacogenetics

Share to Quality-Adjusted Life Years

Source

Identifiers

PMID: 16424826
DOI: 10.1097/01.fpc.0000189801.96220.82

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Screening for the alpha-adducin Gly460Trp variant in hypertensive patients: a cost-effectiveness analysis.PMID 16424826Read ↗

Diuretic therapy, the alpha-adducin gene variant, and the risk of myocardial infarction or stroke in persons with treated hypertension.Semantic proximity Read ↗

Alpha-adducin Gly460Trp polymorphism and hypertension risk: a meta-analysis of 22 studies including 14303 cases and 15961 controls.Semantic proximity Read ↗

Alpha-adducin polymorphism associated with increased risk of adverse cardiovascular outcomes: results from GENEtic Substudy of the INternational VErapamil SR-trandolapril STudy (INVEST-GENES).Semantic proximity Read ↗

Cardiovascular risk in relation to alpha-adducin Gly460Trp polymorphism and systolic pressure: a prospective population study.Semantic proximity Read ↗

Association between alpha-adducin gene polymorphism (Gly460Trp) and genetic predisposition to salt sensitivity: a meta-analysis.Semantic proximity Read ↗

Alpha-adducin Gly460Trp variant increases the risk of stroke in hypertensive Dutch women.Semantic proximity Read ↗

The alpha-adducin Gly460Trp polymorphism and the antihypertensive effects of exercise among men with high blood pressure.Semantic proximity Read ↗

Alpha-adducin and angiotensin-converting enzyme polymorphisms in hypertension: evidence for a joint influence on albuminuria.Semantic proximity Read ↗

Pharmacogenetic-guided selection of warfarin versus novel oral anticoagulants for stroke prevention in patients with atrial fibrillation: a cost-effectiveness analysis.Semantic proximity Read ↗

Cost effectiveness of targeted high-dose atorvastatin therapy following genotype testing in patients with acute coronary syndrome.Semantic proximity Read ↗

Genetic predisposition to salt-sensitivity: a systematic review.Semantic proximity Read ↗

Economic evaluation of pharmacogenomic-guided warfarin treatment for elderly Croatian atrial fibrillation patients with ischemic stroke.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.